Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Interim report Q3 2022

Scandion Oncology will publish its Q3 2022 interim report on Wednesday November 16, 2022, before 09:00 CET. Scandion’s Executive Management will host a webcast and conference call the same day at 10:00 CET presenting the results and a company update. At the end of the presentation there will be a Q&A session. Access to the event can be obtained as follows: LIVE access on Wednesday November 16, 2022, at 10:00 CET Webcast: https://financialhearings.com/event/45864 Dial-in: DK: +4578150110 SE: +46850558354 UK: +443333009266 US: +1 6319131422 PIN US: 42830998# REPLAY access Webcast replay will be available at http://www.scandiononcology.com in the Investors section and at http://www.financialhearings.com For further information please contact: Johnny Stilou, Acting CEO & CFO Phone: +45 2960 3532 E-mail: jos@scandiononcology.com

Redeye Life Science Day

Stockholm , Sweden

Watch the presentation here. We will give a presentation and update on Scandion followed by a Q&A session.

Swiss Biotech Day

Basel Zurich, Switzerland

Meet Scandion Oncology at Swiss Biotech Day.

LSX Nordic Congress

Copenhagen , Denmark

CEO Francois Martelet will take part in panel discussion.

ESMO Congress 2023

Madrid Madrid, Spain

Data from the PANTAX trial will be presented at a poster session.